The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2663-2668

  Levêque, Jean ^a,c   Burtin, Florence ^b   Catros Quemener, Véronique ^a   Havouis, René ^a   Moulinoux, Jacques Philippe ^a  

^a Ctr Reg de Lutte Contre le Cancer   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c Inst de Med Légale   (France)

Author keywords

difluoromethylornithine; Breast cancer; Deprivation; MCF 7 cells; Polyamines

Indexed keywords

EFLORNITHINE; POLYAMINE; PUTRESCINE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; DIET; EFLORNITHINE; FEMALE; HUMANS; INTESTINES; KIDNEY; LIVER; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; POLYAMINES; SPERMINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031809858     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Janne J, Poso H and Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978.
2. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759-774, 1988.
3. Glikman P, Manni A, Demers L and Bartholomew M: Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture. Cancer Res 49: 1371-1376, 1989.
4. Kendra KL and Katzenellenbogen BS: An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen. J Steroid Biochem 28: 123-128, 1987.
5. Hoggard N and Green CD: Polyamines and growth regulation of cultured human breast cancer cells by 17ß-estradiol. Mol Cell Endocrinol 46: 71-78, 1986.
6. Manni A, Badger B, Luk C, Wright C, Caplan R, Rockette H, Bartholomew M and Ahmed SR: Role of polyamines in the growth of the homone responsive experimental breast cancer in vivo. Breast Cancer Res Treat 11: 231-240, 1988.
7. Prakash NJ, Schechter PJ, Grove J and Koch-Weser J: Effect of α-difluoromethylornithine, an enzyme activated irreversible inhibitor of ornithine decarbolxylase, on L1210 leukemia in mice. Cancer Res 38: 3059-3062, 1978.
8. Lima G and Shiu RPC: Role of polyamines in estradiol-induced growth of human breast cancer cells. Cancer Res 45: 2466-2470, 1985.
9. Porter CW and Sufrin JR: Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res 6: 525-542, 1986.
10. Sarhan S, Knodgen B and Seiler N: The gastrointestinal tract as polyamine source of tumor growth. Anticancer Res 9: 215-224, 1989.
11. Seiler N, Sarhan S, Graufel C, Jones R, Knodgen B and Moulinoux JP: Endogenous and exogenous polyamines in support to tumor growth. Cancer Res 50: 5077-5083, 1990.
12. Moulinoux JP, Quemener V, Larzul JJ, Roch AM and Quash GA: Red blood cell polyamine in mice bearing the Lewis lung carcinoma (3 LL) and in patients with bronchopulmonary cancers. Int J Cancer 34: 277-281, 1984.
13. Cipolla B, Moulinoux JP, Quemener V, Havouis R, Martin L, Guille F and Lobel B: Erythrocyte polyamine levels in human prostatic carcinoma. J Urol 144: 1164-1166, 1990.
14. Seiler N and Knodgen B: Determination of polyamines and related compounds by reverse-phase high-performance liquid chromatography: improved separation systems. J Chromatog 339: 45-57, 1985.
15. Bloom J, and Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 357-377, 1957.
16. Gasparini G, Pazza F, Bevilacqua E and Sainsburm J: Growth factor (Ki 67 antibody) determination in early stage breast carcinoma: histologic, clinical and prognostic correlations. The Breast 1: 92-99, 1992.
17. Hamilton PW: Stereology. In: Quantitative clinical pathology, (Hamilton PW and Allen DC, eds) Cambridge, Blackwell Science, 1995, pp 3-15.
18. Cohen FJ, Manni A, Glikman P, Bartholomew M and Demers L: Interactions between growth factor secretion and polyamines in MCF-7 breast cancer cells. Eur J Cancer 26: 603-608, 1990.
19. Thomas T and Thomas T: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res Tr 29: 189-201, 1993.
20. Manni A, Badger B, Martel J, and Demers L: Role of polyamines on the growth of hormone-responsive and-resistant human breast cancer cells in nude mice. Cancer Lett 66: 1-9, 1992.
21. Kremmer T, Palyi I, Daubner D, Boldizsar M, Vincze B, Paulik E, Sugar J, Pokorny E and Tury E: Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Anticancer Res 11: 1807-1814, 1991.
22. Manni A, Wechter R, Wei L, Heitjan D and Demers L: Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylase. J Cell Physiol 163: 129-136, 1995.
23. Manni A: The role of polyamines in the hormonal control of breast cancer cell proliferation. In: Mammary tumorigenesis and malignant progression (Dickson R and Lippman M, eds) New York, Kluwer Academic Publishers, 1994, pp 209-225.
24. Bardocz S, Grant G, Brown DS, Ralph A and Pusztai A: Polyamines in food; implications for growth and health. J Biochem Nutr 4: 66-71, 1993.
25. Moulinoux JP, Darcel F, Quemener V, Havouis R and Seiler N: Inhibition of the growth of the U-251 human glioblastoma in nude mice by polyamine deprivation. Anticancer Res 11: 175-180, 1991 .
26. Quemener V, Moulinoux JP, Havouis R and Seiler N: Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res 12: 1447-1454, 1992.
27. Chamaillard L, Catros-Quemener V, Delcros JG, Bansard JY, Havouis R, Desury D, Commereuc A, Genetet N, and Moulinoux JP: Polyamine deprivation prevents the development of tumour-induced immune suppression. Br J Cancer 76: 365-370, 1997.
28. Balasundaram D and Tyagi AK: Polyamine-DNA nexus: structural ramifications and biological implications. Mol Cell Biochem 100: 129-140, 1991.
29. 2+ transport. Biochem J 286: 597-602, 1992.
30. Cross SJ and Wallac HM: Changes in polyamine concentrations in human breast cancer cells in culture: the effect of serum type and 17ß-oestradiol. Biochem Soc Transact 15: 458-459, 1987.
31. Huber M and Poulin R: Antiproliferative effect of spermine depletion by N-Cyclohxyl-1,3-diaminopropane in human brest cancer cells. Cancer Res 55: 934-943, 1995.
32. Kingnorth AN, Wallace HM, Bundred NJ and Dixon JMJ: Polyamines in breast cancer. Br J Surg 71: 352-356, 1984.
33. Manni A, Mauger D, Gimotty P and Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res 2: 1901-1906, 1996.
34. Manni A, Grove R, Kunzelman S and Aldaz M: Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92: 49-57, 1995.